← Leaderboards
Terrence L Geiger
St. Jude Children'S Research Hospital
$5,188,224
Attributed
$5,188,224
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $798.2K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$5,188,224 · 4
By mechanism
R01$3,866,596 · 1
R21$673,750 · 1
R56$411,250 · 1
K08$236,628 · 1
Top collaborators
No co-investigators on record.
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Hongbo Chi$35,087,263
- Thirumala-Devi Kanneganti$31,618,489
- Derek A Persons$6,676,571
- Arthur W. Nienhuis$5,923,134
- Brian P Sorrentino$13,809,294
Others in their field
Top investigators on “Immunotherapy”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,653,178
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$111,361,061
- Robert H Vonderheide · University Of Pennsylvania$84,159,371
- Sharon A Nachman · Johns Hopkins University$74,725,055
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
Research focus
ImmunotherapyAutoimmunityCell TypeExperimental Autoimmune EncephalomyelitisMultiple SclerosisResponseT-LymphocyteAutoimmune DiseasesMediatingLaboratory MouseReceptorT Cell ReceptorIn VivoSignal TransductionCellsAutoantigensGenetically Modified AnimalsImmunotherapeutic AgentLymphocyteBiochemicalAutoimmune ResponsesLigandsAntigensAnimal Model
Grant awards (16)
Lineage Specific Effects of IL10 In Autoimmunity$411,250
R56 · FY2013 · AI · contact PI
TREATMENT OF AUTOIMMUNITY WITH REGULATORY T LYMPHOCYTES$386,944
R01 · FY2013 · AI · contact PI
TREATMENT OF AUTOIMMUNITY WITH REGULATORY T LYMPHOCYTES$411,642
R01 · FY2012 · AI · contact PI
TREATMENT OF AUTOIMMUNITY WITH REGULATORY T LYMPHOCYTES$411,642
R01 · FY2011 · AI · contact PI
TREATMENT OF AUTOIMMUNITY WITH REGULATORY T LYMPHOCYTES$415,800
R01 · FY2010 · AI · contact PI
TREATMENT OF AUTOIMMUNITY WITH REGULATORY T LYMPHOCYTES$420,000
R01 · FY2009 · AI · contact PI
TREATMENT OF AUTOIMMUNITY WITH RECEPTOR-MODIFIED T CELLS$348,812
R01 · FY2008 · AI · contact PI
TREATMENT OF AUTOIMMUNITY WITH RECEPTOR-MODIFIED T CELLS$355,568
R01 · FY2007 · AI · contact PI
TREATMENT OF AUTOIMMUNITY WITH RECEPTOR-MODIFIED T CELLS$366,188
R01 · FY2006 · AI · contact PI
TREATMENT OF AUTOIMMUNITY WITH RECEPTOR-MODIFIED T CELLS$375,000
R01 · FY2005 · AI
TREATMENT OF AUTOIMMUNITY WITH RECEPTOR-MODIFIED T CELLS$375,000
R01 · FY2004 · AI
Inducing Immune Tolerance with Receptor Modified T Cells$225,000
R21 · FY2003 · AI
Inducing Immune Tolerance with Receptor Modified T Cells$225,000
R21 · FY2002 · AI
Inducing Immune Tolerance with Receptor Modified T Cells$223,750
R21 · FY2001 · AI
TREATMENT OF EAE USING GENETICALLY MODIFIED CTL$118,314
K08 · FY2001 · AI
TREATMENT OF EAE USING GENETICALLY MODIFIED CTL$118,314
K08 · FY2000 · AI